URGENT: The COVID-19 epidemic is severely impacting the progress of ALS research at the ALS Therapy Development Institute. If you are able to give, will you please provide an immediate gift to fund our lab?

 

TDI 209

Scientists at the ALS Therapy Development Institute are testing this small molecule in an attempt to address the oxidative stress observed in the cells of PALS.

Status

Type: Small Molecule
Stage: Active
Status: Active
Sponsor: ALS Therapy Development Institute

TDI Says:

This potential treatment was added in 2015 to our pipeline and is still in the early stages of preclinical research. 

Comment on this Topic

(All comments are moderated before they appear here.)